Lake Morrison, MD
Pulmonary Disease · Durham, NCNPI 1992739619
Payments from drug & device makers
Across 421 payments — averaging $3914.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1.1M
- Roche Products Limited$141K
- United Therapeutics Corporation$122K
- Novartis$88K
- GSK$54K
- Bristol Myers Squibb$52K
- plus $83K from 6 others
Across 12 payments — averaging $130.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 186 | $1,108,284 |
| Roche Products Limited | 24 | $140,882 |
| United Therapeutics Corporation | 32 | $121,850 |
| Novartis | 5 | $88,013 |
| GSK | 16 | $53,828 |
| Bristol Myers Squibb | 4 | $51,987 |
| Boehringer Ingelheim International GmbH | 104 | $35,293 |
| Genentech USA, Inc. | 24 | $27,696 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15,017 |
| F. Hoffmann-la Roche AG | 1 | $2,417 |
| Boehringer Ingelheim Limited | 11 | $1,820 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 13 | $931 |
How this compares
$1,648,018 in reported general payments places this provider in the 95th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Durham
- Laurie SnyderDurham$3.8M
- Scott PalmerDurham$3.8M
- Loretta QueDurham$1.3M
- Robert TigheDurham$824K
- Eric MeltzerDurham$262K
- Craig RackleyDurham$123K
- Scott ShoferDurham$91K
- Selwyn SpangenthalCharlotte$7M
- Thomas SternHuntersville$5.2M
- Michael PritchettPinehurst$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.